FDA And Drug Manufacturer Issue Recall Due To Contamination

January 11th, 2013 | Drug injury

January 11, 2013 The U.S. Food and Drug Administration (FDA) announced earlier this week that it had partnered with Mobius Therapeutics, LLC, in issuing a voluntary market recall of the company’s Mitosol® (mitomycin for solution), 0.2 mg/vial, kit for ophthalmic use. According to a press release from the agency, the recall was issued due to a possible… Read More